| 注册
首页|期刊导航|临床与病理杂志|达卡巴嗪诱导黑素瘤耐药细胞系的建立及其耐药性

达卡巴嗪诱导黑素瘤耐药细胞系的建立及其耐药性

孙金中 孙圣荣 蒋冠

临床与病理杂志2017,Vol.37Issue(11):2305-2309,5.
临床与病理杂志2017,Vol.37Issue(11):2305-2309,5.DOI:10.3978/j.issn.2095-6959.2017.11.004

达卡巴嗪诱导黑素瘤耐药细胞系的建立及其耐药性

Establishment of a dacarbazine-induced resistance melanoma cell line and its drug resistance

孙金中 1孙圣荣 1蒋冠2

作者信息

  • 1. 武汉大学人民医院乳腺甲状腺外科,武汉430060
  • 2. 徐州医科大学附属医院皮肤性病科,江苏徐州221000
  • 折叠

摘要

Abstract

Objective:To establish a melanoma cell line resistant to dacarbazine (DTIC) and to investigate its drug resistance.Methods:O6-methylguananine-DNA methyltransferase (MGMT) protein expression of a human melanoma cell line was detected using Western blot.The drug resistance of human melanoma A375 cells to DTIC was induced by in vitro stepwise induction.Drug-resistant cell line IC50 and resistance index were detected by MTI assay.Results:After treated with DTIC at different concentrations,the growth ofA375 cells slowed down in different degrees.With the increase of DTIC concentration,the inhibition rate ofA375 cells increased in different degrees.The median inhibitory concentration (IC50) of DTIC to in vitro proliferation of parent A375 cells and A375/DTIC cells was 10.766 and 95.693,respectively.The resistance index of A375/DTIC cells to DTIC was 9 times higher than that ofA375 cells (P<0.05).Conclusion:The successful establishment of a DTIC-induced drug-resistant human melanoma cell line A375/DTIC in vitro by gradually increasing the concentration of chemotherapeutic drugs with stages lays an experimental foundation for further study on the mechanism of melanoma resistant to DTIC.

关键词

黑素瘤/达卡巴嗪/O6-甲基鸟嘌呤-DNA甲基转移酶

Key words

melanoma/dacarbazine/O6-methylguananine-DNA methyltransferase

引用本文复制引用

孙金中,孙圣荣,蒋冠..达卡巴嗪诱导黑素瘤耐药细胞系的建立及其耐药性[J].临床与病理杂志,2017,37(11):2305-2309,5.

基金项目

湖北省自然科学基金(2017CFB628).This work was supported by Hubei Provincial Natural Science Foundation,China(2017CFB628). (2017CFB628)

临床与病理杂志

OACSTPCD

1673-2588

访问量0
|
下载量0
段落导航相关论文